Table 1. Baseline characteristics and clinical outcomes after catheter ablation of AF.
Total cohort (n=746) | |||
---|---|---|---|
Baseline characteristics | |||
Age (years) | 59.4±10.6 | ||
Sex (Male) | 548 (73.5) | ||
BMI (kg/m2) | 24.8±2.8 | ||
Paroxysmal AF | 420 (56.3) | ||
Hypertension | 358 (48.1) | ||
DM | 115 (15.4) | ||
Heart failure | 91 (12.2) | ||
History of stroke | 38 (5.2) | ||
Echocardiography | |||
LA dimension (mm) | 42.5±6.4 | ||
LA volume index (mL/m2) | 42.5±15.9 | ||
LVEDD (mm) | 49.3±6.2 | ||
IVSd (mm) | 9.4±1.9 | ||
LVEF | 62.6±8.0 | ||
Clinical outcomes | |||
Median follow-up, days (interquartile range) | 684 (324–1,205) | ||
Recurrence during blanking period* | 21.4 | ||
6-month recurrence | 8.2 | ||
12-month recurrence | 14.7 | ||
Type of recurrence | |||
AF | 57.1 | ||
AFL or AT | 42.9 |
Data are shown as mean±standard deviation or number (%) not otherwise specified.
AF = atrial fibrillation; AFL = atrial flutter; AT = atrial tachycardia; BMI = body mass index; DM = diabetes mellitus; IVSd = interventricular septal thickness at diastole; LA = left atrium; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction.
*The blanking period is within 90 days after catheter ablation.